PreveCeutical Announces Default Judgment Against JCN Capital Corp.

10:02 EDT 8 Apr 2019 | Investing News Network

PreveCeutical Medical Inc. (CSE:PREV, OTCQB:PRVCF, FSE:18H)(the "Company" or "PreveCeutical"), announces that it has obtained a default judgement against JCN Capital Corp. ("JCN") in connection with a Supreme Court of British Columbia action (the "Action").

The post PreveCeutical Announces Default Judgment Against JCN Capital Corp. appeared first on Investing News Network.

Original Article: PreveCeutical Announces Default Judgment Against JCN Capital Corp.

More From BioPortfolio on "PreveCeutical Announces Default Judgment Against JCN Capital Corp."